Siren, L.L.C. Igm Biosciences, Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 3,255,826 shares of IGMS stock, worth $3.97 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,255,826
Previous 3,330,422
2.24%
Holding current value
$3.97 Million
Previous $20.3 Billion
81.6%
% of portfolio
0.21%
Previous 0.9%
Shares
2 transactions
Others Institutions Holding IGMS
# of Institutions
82Shares Held
16.2MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5 Million0.06% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.6 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.07 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY793KShares$967,9300.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $35.3M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...